Atopic dermatitis is a chronic recurrent inflammatory skin disease, characterized by intense itching that causes discomfort for the patients. The heterogenicity of the patient population includes different trajectories. Some are transient, some relapse and others may progress to develop other type II inflammatory diseases. Here you can learn more about the utility of the Nordic Bioscience biomarkers in disease activity, severity, and treatment response in atopic dermatitis.
More about our biomarkers for Atopic Dermatitis
Hidradenitis Suppurativa is characterized as a dermatological disease where the tissue architecture is being remodeled. The main component of the skin are collagens, which are remodeled as a part of the normal homeostasis of the skin. On this page, we explain how our biomarkers for systemic sclerosis can provide such crucial value.
More about our biomarkers for Hidradenitis Suppurativa
There is a need for biomarkers in Psoriasis to improve diagnosis, determine disease severity, predict psoriasis development, and track therapeutic response. All of this will lead to improvement of patient management and reduce clinical trial size and length when developing new efficacious treatments. Here you can get an overview of how the Protein Fingerprint can help in clinical trials associated with Psoriasis.
More about our biomarkers for Psoriasis
Systemic skin diseases with local manifestations, such as scleroderma (systemic sclerosis), are characterized by excessive tissue remodeling and immune cell activity. Tissue-specific biomarkers, quantifying and monitoring epidermal damage, dermal damage, and immune cell activity, are key advantages when we want to understand the disease mechanisms and complexity in scleroderma and lead to targeted successful treatments. On this page, we explain how our biomarkers for scleroderma can provide such crucial value.
More about our biomarkers for Scleroderma
Search and find publications that we have published.
Please don't hesitate to contact us if you have any questions or other inquiries.
